Medicines availability short-term supply issues Last updated 01/05/18
|
|
|
- Scot Conley
- 5 years ago
- Views:
Transcription
1 Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is updated every week. This resource lists all manufacturers of brands and generics in the UK for each product and the current availability status. Medicines are listed alphabetically by generic name, with a brand name specified where applicable, together with the affected pack size(s), availability status and the manufacturer name. Name, form, strength Pack size(s) Brand (if applicable) Manufacturer Next availability update Zovirax GlaxoSmithKline UK Expected early May 2018 Aciclovir dispersible tablets 200mg (NEW) 25 Ranbaxy Aciclovir powder for solution for infusion Zovirax GlaxoSmithKline UK Expected mid May vials 250mg (NEW) available through AAH Adrenaline solution for injection pre-filled 1 Emerade Bausch & Lomb UK Ltd and Phoenix only disposable devices 150mcg/0.15ml (1 in 1000) 1 Jext ALK Abello Ltd Adrenaline solution for injection pre-filled disposable devices 150mcg/0.3ml (1 in 2000) Adrenaline solution for injection pre-filled disposable devices 300mcg/0.3ml (1 in 1000) 1 and 2 Epipen Jr. Meda Pharmaceuticals Ltd available through Alliance Healthcare only available through Alliance Healthcare only available through AAH 1 Emerade Bausch & Lomb UK Ltd and Phoenix only Packs of 1 in stock and packs of 2 1 and Epipen Meda Pharmaceuticals Ltd unknown available through 2 Alliance Healthcare only 1 Jext ALK - Abello Ltd available through
2 Adrenaline solution for injection pre-filled disposable devices 500mcg/0.5ml (1 in 1000) 1 Emerade Bausch & Lomb UK ltd Alliance Healthcare only available through AAH and Phoenix only Aldactide tablets 50mg 28 Pfizer Expected 1 June 2018 Amlodipine tablets 5mg 28 Dr Reddy s Laboratories Expected end of May 2018 Sandoz Amlodipine tablets 10mg 28 Dr Reddy s Laboratories Expected end of May 2018 Istin Pfizer Sandoz Expected 7 May 2018 AstraZeneca Atenolol tablets 50mg 28 Strides Shasun
3 Azithromycin oral suspension 200mg/5ml 30 mls (NEW) Bisacodyl tablets 5mg 30ml 60, 100, 500 and 1000 Calcium and Ergocalciferol tablets 28 Carbamazepine sugar free oral suspension 100mg/5ml Dipyridamole modified release capsules 200mg Doxycycline dispersible tablets sugar free 100mg (NEW) Zithromax Pfizer Expected 3 May 2018 Sandoz Chanelle Medical Packs of 500 expected July 2018 and packs of 1000 in stock Dr Reddy s Laboratories Genesis Pharmaceuticals Dulcolax Sanofi Expected 8 May 2018 Crescent Zanza Labs 300ml Expected w/e 4 May Persantin Retard Boehringer Ingelheim Attia Dr Reddy s Laboratories Ofcram Focus Expected May Vibramycin D Pfizer Expected w/e 18 May 2018 Duloxetine gastro resistant capsules 60mg 28 Duciltia Aristo Pharma Aspire Expected May 2018 Consilient Health Creo Pharma Dr Reddy s Laboratories Cymbalta Eli Lilly HBS Healthcare Rivopharm Zentiva
4 Expected 2 May 2018 Aspire Eplerenone tablets 25mg (NEW) 28 Creo Pharma Mylan Inspra Pfizer Expected w/e 4 May 2018 Pfizer Zentiva Aspire Eplerenone tablets 50mg (NEW) 28 Creo Pharma Inspra Pfizer Expected w/c 14 May 2018 Pfizer Expected w/e 5 May 2018 Zentiva Expected 28 May 2018 Chanelle Pharma Fexofenadine tablets 180mg 30 Dr Reddy s Laboratories Zentiva Fluoxetine dispersible tablets sugar free Concordia International 28 Olena 20mg (Amdipharm) Expected mid May 2018 Expected 30 April 2018 Laboratories Fluoxetine capsules 60mg 30 Dr Reddy s Laboratories Focus Pharmaceuticals Milpharm Medreich Mylan Fluticasone ointment 0.005% 15g Cutivate GlaxoSmithKline UK Expected late May 2018 Gemcitabine powder for solution for 1 Expected end of July 2018
5 infusion vials 1g Eli Lilly Pfizer (Hospira) Expected 29 June 2018 Sun Pharmaceuticals UK Bilxona Packs of 28 in stock and packs of 56 expected 22 May 2018 Zicron Concordia International 28 and Vamju (Amdipharm) 56 Gliclazide modified release tablets 30mg Glyceryl trinitrate solution for infusion ampoules 25mg/5ml (NEW) Human papillomavirus(type 16,18) vaccine (adsorbed) suspension for injection prefilled syringes 0.5ml Hypromellose eye drops 0.3% Latanoprost eye drops 50mcg/1ml (NEW) Nazdol MR Consilient Health Ziclaseg Lupin Diamicron MR Servier Laboratories Edicil 5 Pfizer Expected w/e 18 May 2018 (Hospital only) 1 Cervarix GlaxoSmithKline UK Expected Quarter ml 2.5ml Blumont Healthcare Vizulize Hypromellose East Midlands Pharma Mandanol M & A Pharmachem Martindale (Hospital only) Lumecare Medicom Healthcare Brolene Cool Eyes Sanofi Expected w/c 25 June 2018 Sai-Meds Expected w/c 20 July 2018 Martindale Pharma Medizol Medicom Healthcare Ltd Xalatan Pfizer Pfizer
6 Latanoprost 50mcg/1ml and timolol 5mg/1ml eye drops 2.5ml Zentiva Expected w/c 7 May 2018 Kent Pharmaceuticals Martindale Xalacom Pfizer Zentiva Expected w/c 14 May 2018 Levodopa/Carbidopa/Entecapone tablets 75/18.5/200mg 30 Sastravi Expected 14 May 2018 Levodopa/Carbidopa/Entecapone tablets 100/25/200mg 30 Sastravi Expected 14 May 2018 Levodopa/Carbidopa/Entecapone tablets 200/50/200mg 30 Sastravi Expected 14 May 2018 Medroxyprogesterone tablets 200mg (NEW) Memantine tablets 10mg 56 Metformin tablets 500mg 28 Mometasone furoate ointment 0.1% 30 Provera Pfizer Expected w/e 11 May g Marixino Consilient Health Crescent Niche Generics Expected July 2018 Expected 11 May 2018 Crescent Milpharm Relonchem Expected 9 May 2018 Glenmark Merck Sharp & Dohme
7 Mylan Expected mid July 2018 Ondansetron tablets 4mg 30 Novartis Oxybutynin tablets 2.5mg 56 and Niche Generics Expected early June Ditropan Sanofi Strides Shasun Oxybutynin tablets 5mg 56 and Niche Generics Expected early June Ditropan Sanofi Strides Shasun Expected 30 April 2018 Phenoxymethylpenicillin oral solution Laboratories 100ml sugar free 125mg/5ml Brown & Burk Expected mid May 2018 Kent Pharmaceuticals Quinapril tablets 20mg 28 Accupro Pfizer Expected 25 May 2018 Quinapril tablets 40mg (NEW) 28 Accupro Pfizer Expected w/e 25 May 2018 Ranitidine tablets 300mg 30 Zantac GlaxoSmithKline UK Expected late April 2018
8 Ranitidine solution for injection ampoules 50mg/2ml (NEW) Ranitidine oral solution sugar free 75mg/5ml (NEW) 5 300ml Risperidone tablets 1mg 20 Rizatriptan orodispersible tablets 10mg Salbutamol solution for injection ampoules 5mg/5ml (NEW) 3 and 6 Sildenafil film coated tablets 50mg 8 Tobramycin solution for injection vials 240mg/6ml (NEW) Tolterodine tablets 2mg Expected 11 May 2018 Concordia International Expected w/e 4 May 2018 Zantac GlaxoSmithKline UK Expected early June 2018 Focus GlaxoSmithKline UK Expected mid May 2018 Expected 26 May 2018 Aurobindo Expected 11 May ml Ventolin GlaxoSmithKline UK Expected late May 2018 Expected May 2018 Macleods Expected w/c 30 April 2018 Milpharm Mylan Pfizer Expected 11 May Pfizer Expected end of May Expected end of May 2018 Aspire Expected May 2018 Detrusitol Pfizer
9 Sandoz Expected end of April 2018 Tolterodine modified-release capsules 4mg Preblacon Expected 9 July 2018 (NEW) Neditol Aspire Detrusitol Pfizer 28 Santizor Pfizer Iconex Sandoz Mariosea Blerone Zentiva Tolterodine modified release capsules 4mg 28 Detrusitol XL Pfizer Expected 1 June Santizor XL Pfizer Creo Pharma Tranexamic acid tablets 500mg 60 Manx Healthcare Cyklokapron Meda Pharmaceuticals Rivopharm Sandoz Expected end of July 2018 Vincristine sulphate solution for injection vials 2mg/2ml 5 Pfizer Expected 25 May 2018 Vincristine sulphate solution for injection vials 5mg/5ml 5 Pfizer Expected 15 June 2018 Xylocaine pump spray 10mg/dose 50ml Aspen Expected 20 May 2018
Medicines availability
The resource includes availability information on medicines that are reported to have supply issues, with next expected availability. Medicines are listed alphabetically by generic name, with a br name
Medicines availability
The resource includes availability information on medicines that are reported to have supply issues, with next expected availability. Medicines are listed alphabetically by generic name, with a br name
Medicines availability
The resource includes availability information on medicines that are reported to have supply issues, with next expected availability. Medicines are listed alphabetically by generic name, with a br name
Medicines availability long-term supply issues Last updated 10/04/18
Long-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability greater than three months or no known date.
Medicines availability
The resource includes availability information on medicines that are reported to have supply issues, with next expected availability. Medicines are listed alphabetically by generic name, with a brand name
Medicines availability
The resource includes availability information on medicines that are reported to have supply issues, with next expected availability. Medicines are listed alphabetically by generic name, with a brand name
DT Description Price Category Price change
Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining
MANUFACTURING PROBLEMS AS OF 15th February 2016
MANUFACTURING PROBLEMS AS OF 15th February 2016 Drug Manufacturer Brand Name Comments Suggested Aciclovir 3% Eye Ointment 4.5gram Zovirax Out of stock - not due until end of March 2016 Amoxycillin powder
MANUFACTURING PROBLEMS AS OF 29th February 2016
MANUFACTURING PROBLEMS AS OF 29th February 2016 Drug Manufacturer Brand Name Comments Amoxycillin powder for Injection 1gram x 10 Amoxycillin powder for Injection 500mg x 10 Amoxycillin & Clavulanic 600mg
DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %
June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has
DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %
December 16 No Category M changes so the reductions imposed in May which were only supposed to last until September continue As in November, most changes are Category A lines with a few Category C. Significant
While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.
April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more
Marketing authorisations granted in September 2012
PL 00037/0648 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 250 MG FILM-COATED TABLETS LEVETIRACETAM 250 MILLIGRAMMES POM PL 00037/0649 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 500 MG FILM-COATED
DT Description Price Category Price change Percentage
June 2017 A slight inflationary pressure in most CCGs from mainly Category A increases. Significant price increases: Most of low concern although those involving the less frequently used tamoxifen strengths
Award of Contracts without Competition December 2013
SERIVCES 2850 Open Text Opentext Web CMS Software Support 125,000.00 Business Services Organisation 2259 Lynas Cooked Pork (Lynas) 63,063.00 2703 Limavady Office Products 169,477.00 2817 Merck no 3 Nutritional
Pharma X Consultancy Inc. Inventory List
Pharma X Consultancy Inc. Inventory List Location: Pharma X Consultancy Inc 2 Aceclofenac 100mg Tablets 60S 1205 ID Aciclovir 200mg Tablets 25S 1213 Aciclovir 400mg Tablets 56S 1214 Aciclovir 5% Cream
Kern Pharma Portfolio 2014
Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN
P R O D U C T L I S T S E P T E M B E R
PRODUCT LIST SEPTEMBER 2017 Alprazolam Tablets, USP CIV (brand-name Xanax ) 59762-3719-1 0.25 mg tablets 100 tablets/bottle 48 59762-3719-3 0.25 mg tablets 500 tablets/bottle 48 59762-3719-4 0.25 mg tablets
Advance Notification of Amendments to the December 2018 Drug Tariff
Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen
Advance Notification of Amendments to the August 2018 Drug Tariff
Advance Notification of Amendments to the August 2018 Drug Tariff ADDITIONS Zero Discount Brivaracetam 100mg tablets Brivaracetam 25mg tablets Brivaracetam 50mg tablets Brivaracetam 75mg tablets Maraviroc
P R O D U C T L I S T N O V E M B E R
PRODUCT LIST NOVEMBER 2018 Alprazolam Tablets, USP CIV (brand-name Xanax ) 59762-3719-1 0.25 mg tablets 100 tablets/bottle 48 59762-3719-3 0.25 mg tablets 500 tablets/bottle 48 59762-3719-4 0.25 mg tablets
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
PBS PRICE INCREASES - AUGUST 2014 SCHEDULE
Price increase review - general PBS benzylpenicillin 600 mg injection, 1 x 600 mg vial 1775K, 3398W, BenPen 3.84 4.38 3486L benzylpenicillin 3 g injection, 1 x 3 g vial 2647H, 3399X, BenPen 6.60 7.55 3487M
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS
SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets
PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5
Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605
Advance Notification of Amendments to the June 2018 Drug Tariff
Advance Notification of Amendments to the June 2018 Drug Tariff ADDITIONS Zero Discount Tacrolimus 1mg modified-release capsules Part I - Drugs And Preparations Special Container * This pack only (others
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014
28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some
Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product
PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6
Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;
Rajasthan Medical Services Corporation Limited, Jaipur
Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
29 February 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2014/15 Invitation to Tender, d 6 November 2014, and
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
Identifying High Greenhouse Gas Intensity Prescription Items for NHS in England. Final Report. February 2014
Identifying High Greenhouse Gas Intensity Prescription Items for NHS in England Final Report February 2014 Delivering sustainable solutions in a more competitive world Sustainable Development Unit Identifying
requesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group
July 2015 Our Ref: FOI.15.CAN0059 requesting information regarding Rebate and QIPP prescribing schemes in NHS Canterbury and Coastal Clinical Commissioning Group Could you please provide me with the details
Chapter 2 ~ Cardiovascular system
Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
Advance Notification of Amendments to the March 2018 Drug Tariff
Advance Notification of Amendments to the March 2018 Drug Tariff ADDITIONS Zero Discount Terbutaline 2.5mg/5ml solution for injection ampoules Part I - Drugs And Preparations Special Container * This pack
UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:
1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A 294.3 for use in Northern Ireland) Sep 2015 BNF 1.3.5 Proton pump inhibitors Lansoprazole orodispersible
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014
30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
Advance Notification of Amendments to the March 2017 Drug Tariff
Advance Notification of Amendments to the March 2017 Drug Tariff ADDITIONS Part I - Drugs And Preparations Special Container Drug Qty Price Acetylcysteine 600mg capsules 30 39.95 A Caffeine citrate 50mg/5ml
Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
Information for Vermont Prescribers of Prescription Drugs Long Form
Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
Advance Notification of Amendments to the April 2015 Drug Tariff
Advance Notification of Amendments to the April 2015 Drug Tariff ADDITIONS Part I - Drugs And Preparations Drug Qty Price Chlorambucil 2mg tablets 25 40.51 A Melphalan 2mg tablets 25 42.88 A Part III Appliances
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
Anti Diabetic. BE Reference product. Diamicron Gliclazide MR Tablets 60 mg (Servier, France) HCl XR Tablets 500 mg (BMS, US)
Anti Diabetic Gliclazide 30/60 mg ER Tablets Diamicron Gliclazide MR Tablets 60 mg (Servier, France) Tajikistan (Under registration), Vietnam, Uzbekistan US (Filed 2010) US (2013) India (2006), Vietnam
Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro
Quality of medicines in Portugal: a retrospective review of medicine recalls (2005-2015) Ana Teresa Reis Bruna Berardo Rui Loureiro Introduction Human medicines Cosmetics Veterinary medicines Medical devices
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Technology Appraisals and Guidance Information Services Static List Review (SLR) report Title and TA publication number of static topic: Final decision:
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 April 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, d 3 November
Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria
ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least
Advance Notification of Amendments to the February 2019 Drug Tariff
Advance Notification of Amendments to the February 2019 Drug Tariff ADDITIONS Zero Discount Fidaxomicin 200mg tablets Tobramycin 28mg inhalation powder capsules with device Part I - Drugs And Preparations
Supply should only occur if requesting signature is on approved list held by the issuing pharmacy
Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the
FREEDOM OF INFORMATION DECISION NOTICE. FOI Reference Number: 870
Scarsdale Nightingale Close Newbold Chesterfield S41 7PF Tel.: 01246 514048 Date: 5 June 2018 FREEDOM OF INFORMATION DECISION NOTICE Dear Sir / Madam, FOI Reference Number: 870 I refer to your email of
Good practice for drug calculations
Good practice for drug calculations A step-by-step guide for nurses, doctors and all other healthcare professionals Pharmacyservices 7048 Drug Cal Guide A6 Update_AW.indd 1 22/07/2014 09:55 2 Contents
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
DATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS:
UHS FC: 8703417 Dr. Marilyn Reaño 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic 120 btl 70.00 8,400.00 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic 240 btl 70.00 16,800.00
Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)
The Hospital Medicines List (HML) Section H for Hospital Management Agency Pharmaceuticals Update Update effective 1 August 2014 New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for
Palliative Coverage Drug Benefit Supplement
Palliative Coverage Drug Benefit Supplement Effective April 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Electronic Prescription Service (EPS) dm+d and Prescribing Systems
Electronic Prescription Service (EPS) dm+d and Prescribing Systems dm+d and Prescribing Systems The NHS Dictionary of Medicines and Devices (dm+d) is the standard for transferring medicine and medical
RECALL NOTICES 2014 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS
RECALL NOTICES 2014 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS Aug 28, 2014 Fougera recalls to the WHOLESALE Level Fluocinonde Gel USP 60gm 00168-0135-60 Multiple Lots Fluocinonde
NEW Products - January 2019
NEW Products NEW Products - January 2019 NEW 4040895 Buprenorphine TSD Patches 35mcg (Relevtec) 4 4040903 Buprenorphine TSD Patches 52.5mcg (Relevtec) 4 4040911 Buprenorphine TSD Patches 70mcg (Relevtec)
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes
30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
NEW Products - September 2018
NEW Products NEW Products - September 2018 NEW Generics 3 4 42 61 67 71 NEW Products Generics Parallel Imports UK Ethicals UK Feeds PI Import Feeds www.de-group.co.uk 1027200 Ibuprofen Tablets 400mg 250
Volume 4; Number 17 November 2010
Volume 4; Number 17 November 2010 USE OF UNLICENSED PHARMACEUTICAL SPECIALS What are pharmaceutical specials? A pharmaceutical special as defined by law is a medicine made to satisfy an individual patient
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014
30 April 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED
NHS Pharmaceutical Quality Assurance Service Safe Medication Bulletin
NHS Pharmaceutical Quality Assurance Service Safe Medication Bulletin Divisional Contracts Wave 8b 33% (DCE and DSW) This Bulletin alerts users to products accepted for the National Contracts which have
NEW Products - October 2018
NEW Products NEW Products - October 2018 NEW Generics 1224773 Buprenorphine Tablets 2mg/Naloxone 0.52mg 28 1224765 Buprenorphine Tablets 8mg/Naloxone 2mg 28 1223494 Captopril Oral Solution 5mg/5ml S/F
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube On Aug. 24, 2015, Allergan recalled three lots (86258 expires September 2017, 87189 December 2017 and 87514 February
CONTRACT UPDATE July 20, 2012
CONTRACT UP July 20, 2012 ADDS AMPHETAMINE SALT MIX ER CAPSULE 10MG 100 002-3059-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER CAPSULE 20MG 100 002-3060-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER
NEW Products - December 2018
NEW Products NEW Products - December 2018 NEW Generics 7818925 Colecalciferol Tablets 800iu (No PL) 30 1144773 Famciclovir Tablets 125mg 10 1144757 Famciclovir Tablets 500mg 14 122382 Fluticasone Propionate
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and
NIT 97 - APPROVED DRUG LIST
1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
No. Description Packing UOM
Republic of the Philippines PITC Pharma, Inc. Bids and Awards Committee INVITATION TO BID VARIOUS GENERIC & ONCOLOGY MEDICINES, MEDICAL DEVICE & SUPPLIES (PROJECT REF. NO. BAC/GOODS 2016-02-002) The PITC
TODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
Contents. Delivering Value Together. New Products. Generics. Parallel lmports. UK Ethicals. UK Feeds. Parallel lmport Feeds.
Delivering Value Together Contents New Products Generics Parallel lmports UK Ethicals UK Feeds Parallel lmport Feeds Dressings 2 3 21 35 37 41 44 For full terms & conditions please visit www.de-group.co.uk
Règlement modifiant le Règlement sur les médicaments couverts. Specified Drugs Regulation, amendment
THE PRESCRIPTION DRUGS COST ASSISTANCE ACT (C.C.S.M. c. P115) Specified Drugs Regulation, amendment LOI SUR L'AIDE À L'ACHAT DE MÉDICAMENTS SUR ORDONNANCE (c. P115 de la C.P.L.M.) Règlement modifiant le
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
Information for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets)
Information for Vermont Prescribers of Prescription Drugs Lunesta (eszopiclone tablets) This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.
Advance Notification of Amendments to the November 2017 Drug Tariff
Advance Notification of Amendments to the November 2017 Drug Tariff ADDITIONS Pyridostigmine bromide 180mg modified-release capsules Special Container * This pack only (others already listed) Drug Qty
Innovative Products Available. OTC Products Available
Innovative Products Benfotiamine film-coated tablets 150 mg Cholecalciferol film-coated tablets 22400 I.U. Diltiazem rectal ointment 2% Agents for Treatment of Hemorrhoids and Fissures Blood and Blood